A warfarin treated patient unexpectedly presented with an elevated international normalized ratio (INR). Repeat testing in two laboratories gave conflicting results. The chromogenic assay of factor X was used to determine the correct INR result. The patient had laboratory results consistent with a dysfibrinogenemia, which prevented detection of the endpoint with a photo-optical detection system. The chromogenic assay of factor X is recommended for monitoring patients on warfarin when the INR cannot be accurately determined due to interference with the fibrin endpoint in the INR. ©2009 Marshfield Clinic.
CITATION STYLE
Sanfelippo, M. J., Zinsmaster, W., Scherr, D. L., & Shaw, G. R. (2009). Use of chromogenic assay of factor X to accept or reject INR results in warfarin treated patients. Clinical Medicine and Research, 7(3), 103–105. https://doi.org/10.3121/cmr.2009.836
Mendeley helps you to discover research relevant for your work.